RATIONALE: Food protein-induced allergic proctocolitis (FPIAP) is an early, common, and burdensome manifestation of food allergy. Yet, its epidemiology, pathophysiology and relationship to other food allergic manifestations remain poorly understood. METHODS: The Gastrointestinal Microbiome and Allergic Proctocolitis (GMAP) Study is an ongoing prospective observational infant cohort which enrolled 1003 healthy newborn infants at their first well visit at a single primary care practice in suburban Massachusetts and followed them for a median of 24 [2, 45] months. Clinical diagnosis of FPIAP including documented blood in stool was made by expert clinicians. RESULTS: 903 infants were analyzed (46% female, 89% term, 32% delivered via caesarian section, 9% neonatal antibiotics). 153 cases of FPIAP were identified, giving a cumulative incidence of FPIAP in this unselected population of 17% over three years. Infants fed both breastmilk and formula at any point during the first 4 months were 56% less likely than infants fed exclusively formula and 38% less likely than infants fed exclusively breastmilk to develop FPIAP (HR 0.44, p50.005; HR 0.62, p<0.050). Eczema (OR 1.5 [1.1, 2.2], p50.021) and family history of food allergies (OR 1.9 [1.2, 2.8], p50.005) were among risk factors for FPIAP development, while caesarian section, antibiotic exposure, and siblings were not. Infants fed exclusively formula developed FPIAP at a significantly younger age than those exposed to breastmilk (15.6 vs. 32.4 days, p<0.001). CONCLUSIONS: The prospectively defined incidence of FPIAP is strikingly higher than published estimates. Infants fed both formula and breastmilk appeared most protected against FPIAP development.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.